Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials
about
Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitisPrognostic value of PD-L1 expression in tumor infiltrating immune cells in cancers: A meta-analysis.Tumor-Localized Secretion of Soluble PD1 Enhances Oncolytic Virotherapy.Analyses of selected safety endpoints in phase 1 and late-phase clinical trials of anti-PD-1 and PD-L1 inhibitors: prediction of immune-related toxicities.Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer.Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis.Primary hypothyroidism and isolated ACTH deficiency induced by nivolumab therapy: Case report and review.In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease.Isolated Adrenocorticotropin Deficiency due to Nivolumab-induced Hypophysitis in a Patient with Advanced Lung Adenocarcinoma: A Case Report and Literature Review.Potential Risk Factors for Nivolumab-induced Thyroid Dysfunction.Characterization and implications of thyroid dysfunction induced by immune checkpoint inhibitors in real-life clinical practice: a long-term prospective study from a referral institution.First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies.Myocarditis with tremelimumab plus durvalumab combination therapy for endometrial cancer: A case report.An Extremely Rapid Case of Pneumonitis with the Use of Nivolumab for Pancreatic Adenocarcinoma.Cardiotoxicity of immune checkpoint inhibitors.Real world experience in low-dose ipilimumab in combination with PD-1 blockade in advanced melanoma patients.Toxicity of Checkpoint Inhibition in Advanced RCC: A Systematic ReviewClinical Safety of Combined Targeted and L. Therapy in Oncological PatientsAnti-PD-1 therapy for clinical treatment of lymphoma: a single-arm meta-analysis
P2860
Q33813378-358C6378-9850-4BE9-AD1E-38788A619046Q36358014-6ED92E78-5F0A-4106-B86B-22FDA6FE0C07Q40287020-51EA0BA0-8848-478A-9155-91F7E6B6C1FAQ42188216-49F854AF-89C0-4EAC-B00D-80017B2C4762Q47094041-15B35BFB-A64D-454E-B4D1-BB914A489528Q47101155-22941210-3FED-4677-A995-A9C5460F27DFQ47111469-E1DC1D1B-3D22-4FAF-B963-B25C86CB4962Q47553772-59763E29-FCC6-4348-BB84-7F3EC3557A21Q47707565-801EADC2-887B-472A-966D-9E1E644EFFA7Q49295734-A370055C-67D5-479D-89A4-B309CACA27FBQ50086190-1358C8F8-6C2C-442F-8686-35A5D58D25E7Q53068022-AFA0114A-54C8-47DA-BA2F-185EDEB53A65Q55281940-7B20D235-58C9-4BA9-B698-2620E51EF784Q55410730-C89A0EB3-4A52-465F-809D-2A361EF18183Q55438414-7E22D6F8-2458-42D9-B7D4-1DC91F9EF372Q55496359-311FDFCD-8B2F-432A-B5EA-0CF69B4FABCEQ58585047-41B0FCB8-4650-4EDE-BD16-5C482CB94C34Q58760840-57E1C28D-AB35-48C6-8045-C1B0CF376663Q59132267-2B10E52D-23B8-4F60-ABF3-7888855673C2
P2860
Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Toxicity profile of approved a ...... of randomized clinical trials
@ast
Toxicity profile of approved a ...... of randomized clinical trials
@en
Toxicity profile of approved a ...... of randomized clinical trials
@nl
type
label
Toxicity profile of approved a ...... of randomized clinical trials
@ast
Toxicity profile of approved a ...... of randomized clinical trials
@en
Toxicity profile of approved a ...... of randomized clinical trials
@nl
prefLabel
Toxicity profile of approved a ...... of randomized clinical trials
@ast
Toxicity profile of approved a ...... of randomized clinical trials
@en
Toxicity profile of approved a ...... of randomized clinical trials
@nl
P2093
P2860
P31
P921
P356
P1433
P1476
Toxicity profile of approved a ...... of randomized clinical trials
@en
P2093
Alfred W. Rademaker
Benedito A. Carneiro
Francis J. Giles
Jeffrey A. Sosman
Mark Agulnik
Massimo Cristofanilli
Ricardo Costa
Sachin G. Pai
Victoria M. Villaflor
P2860
P356
10.18632/ONCOTARGET.13315
P407
P5008
P577
2016-11-11T00:00:00Z
2017-01-31T00:00:00Z